Navigation Links
Microbia, Inc. Names Mike Doyle as Senior Vice President and General Manager, Nutrition Ingredients
Date:4/2/2009

Microbia, Inc. (Microbia), an emerging leader in the production of sustainable, specialty ingredients and biomaterials from fermentation technology, has announced that Mike Doyle has joined the company as senior vice president and general manager of nutrition ingredients. Mike is the former director of nutrition health business for BASF and will lead Microbia's food ingredients business initiatives. For more information about Microbia, please go to http://www.microbia-pe.com/.

Lexington, Mass., April 2, 2009-- Microbia, Inc. (Microbia), an emerging leader in the production of sustainable, specialty ingredients and biomaterials from fermentation technology, has appointed Mike Doyle to the newly created position of senior vice president and general manager of nutrition ingredients. Mr. Doyle will have broad responsibility for all aspects of Microbia's nutrition ingredients business, including strategic planning, marketing, sales, operations, supply chain management and strategic partnerships in preparation for the launch of Microbia's line of naturally derived carotenoids for the food ingredient and nutritional supplement markets.

"Microbia's goal is to utilize our proprietary, bio-based technology platform to produce nutritional ingredients that will help the food and feed industries make products more innovative, cost-effective and environmentally sustainable," said Richard Bailey, Ph.D., CEO of Microbia. "Mike Doyle has the experience, energy and skills required to lead this effort, and holds a track record of success managing relevant nutrition businesses. We look forward to drawing on his substantial expertise to establish a strong position in the nutrition
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. KGI Names Kerry Howell Vice President for Advancement
2. Vical Names Andrew de Guttadauro Vice President, Corporate Development
3. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
4. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
5. CryoLife Names Philip Theodore as Vice President, General Counsel
6. Genstar Names Michael Hurt to Its Strategic Advisory Board
7. PPD Names Daniel Darazsdi as Chief Financial Officer
8. Society of Laproendoscopic Surgeons Names Starion Instruments 2007 Innovator of the Year
9. Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance
10. Mpex Pharmaceuticals Names Dr. Jeffery Loutit as Chief Medical Officer
11. Osprey Pharmaceuticals Names Jack M. Anthony as CEO
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Microbia, Inc. Names Mike Doyle as Senior Vice President and General Manager, Nutrition Ingredients
Microbia, Inc. Names Mike Doyle as Senior Vice President and General Manager, Nutrition Ingredients
Breaking Biology Technology:Myriant Technologies LLC Selected for $50 Million Award for Succinic Acid Biorefinery Project 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6EUCODIS Bioscience Appoints Thomas Fischer as New CEO 2Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 2Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 3